EVI News Letter no. 3 now available
The third EVI News Letter covering the period July - December 2011 can be downloaded.
Welcome to TRANSVAC, a collaborative infrastructure project funded under the European Commission’s (EC) 7th Framework Programme (FP7). The project is the joint effort of leading European groups in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC was designed in order to enhance European research and training and foster the seamless implementation of a permanent research infrastructure for early vaccine development in Europe.
TRANSVAC aims to accelerate the development of promising vaccine candidates by bridging the gap between bench research and clinical trials through the provision of expertise on e.g. antigen discovery, formulation, in vivo models and antigen production. The project will be the European driving force for vaccine development by establishing an efficient sustainable collaborative infrastructure based on a shared visions and goal.
In order to reach its ambitious goal, TRANSVAC carries out activities at various levels. On this website you can find out about how to benefit from TRANSVAC’s portfolio of activities, learn how to apply for access to the TRANSVAC’s high-quality Infrastructure Services (Open Call), how to participate in the free Workshops on Animal Models or in the free Modular Course on Concepts on Vaccine Development. Finally, TRANSVAC looks to the future and is exploring the implementation of a road map towards a sustainable European vaccine development platform beyond TRANSVAC. This is done by the European Vaccine Development Stakeholder Working Groups.
APPLY NOW FOR THE CALL FOR NEW PARTNERS (Deadline: 15 March 2012)
In order to sustain vaccine research infrastructure in Europe, the TRANSVAC consortium will consider the integration of new partners into the TRANSVAC infrastructure, mainly when they can offer are services which are not covered by the current work plan.
The services provided by the potential new partners will be integrated in the advertising plan and the transnational access call in order for the potential new partners to extend their network and make their services available on a paid basis to the scientific community.
APPLY NOW FOR THE 5th CALL FOR FREE SERVICES (Deadline: 31 January 2012)
The third EVI News Letter covering the period July - December 2011 can be downloaded.
The call text and application form can be accessed via the Apply now page
Report of the 2011 TRANSVAC Workshop on translational vaccine research and training available